Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

German Diabetes-Diet-Intervention and Energy Restriction-Trial (DDIET) (DDIET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01409330
Recruitment Status : Unknown
Verified August 2012 by German Diabetes Center.
Recruitment status was:  Recruiting
First Posted : August 4, 2011
Last Update Posted : August 22, 2012
Sponsor:
Information provided by (Responsible Party):
German Diabetes Center

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

Diet intervention according to the German Diabetes Risk Score in newly diagnosed type 2 diabetes.

This study aims to explore the effect of diet lacking red meat, but containing increased fibers and coffee (verum) versus standard recommendation (control) in a multicenter setting.


Condition or disease Intervention/treatment Phase
Type 2 Diabetes Dietary Supplement: diet intervention Phase 4

Detailed Description:

This study is a randomised, multicenter controlled trial Our Aim is to test the effects of an 8-week diet lacking red meat, containing increased fibers and coffee (verum) versus standard recommendation (control)in a multicenter setting.

We are expecting that the verum diet will improve insulin sensitivity and insulin secretion due to reductions in visceral and hepatic fat along with improved adipocyte cytokine secretion profiles

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Short Term Diet Intervention in Newly Diagnosed Type 2 Diabetes. a Randomised, Multicentric, Controlled, Clinical Trial
Study Start Date : February 2011
Estimated Primary Completion Date : September 2013
Estimated Study Completion Date : December 2013

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: hypocaloric diet containing increased fibers and coffee
In the intervention group the patients are allowed to eat only white meat and fish. They also need to increase their daily fiber intake to 50grams and drink 5 cups of coffee a day.
 Dietary Supplement: diet intervention
8-week diet lacking red meat, but containing increased fibers and coffee (verum) versus standard recommendation (control) eating red meat.
Active Comparator: hypocaloric diet containing red meat
control group (n=20): diet according to the ADA/EASD guidelines (50% carbohydrates, 20% proteins, 30% fat). In the control group the patients should eat 150 grams of red meat a day and are not allowed to consume alcohol, coffee and whole grains.
 Dietary Supplement: diet intervention
8-week diet lacking red meat, but containing increased fibers and coffee (verum) versus standard recommendation (control) eating red meat.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. whole body insulin sensitivity [ Time Frame: 8 weeks ]
    measurement of whole body insulin sensitivity with hyperinsulinamic euglicamic clamp


Secondary Outcome Measures :
  1. total body fat [ Time Frame: 8 weeks ]
    MRI measurement of the effects of 8-week diet intervention on total body fat

  2. intramyocellular lipids [ Time Frame: 8 weeks ]
    MRS measurement to investigate the effects of diet intervention on ectopic lipid content in skeletal muscle

  3. skeletal muscle mitochondrial function [ Time Frame: 8 weeks ]
    muscle biopsy for assessment of insulin signaling

  4. hepatocellular lipids [ Time Frame: 8 weeks ]
    MRS measurement to investigate the effects of diet intervention on ectopic lipid content in liver(HCL)

  5. skeletal muscle mitochondrial function [ Time Frame: 8 weeks ]
    skeletal muscle mitochondrial function in vivo assessed as phosphate-recovery time with MRS

  6. insulin secretion [ Time Frame: 8 weeks ]
    measurement of insulin secretion with glucagon test, mixed-meal test and intravenous glucose tolerance test

  7. pancreatic fat [ Time Frame: 8 weeks ]
    MRI measurement of the effects of 8-week diet intervention on pancreatic fat


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 69 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Type 2 diabetic patients
  • disease duration for five years or less,
  • age of 69 years or less,
  • body mass index of 30 kg/m2 or more,
  • hemoglobin A1c of 5,5 % to 9%
  • patient should be on standard diet or metformin +/- acarbose monotherapy
  • patient should be without exclusion criteria for coffee consumption

Exclusion Criteria:

  • disease duration more than five years,
  • age of > 69 years,
  • body mass index of < 30 kg/m2,
  • hemoglobin A1c < 5,5 % or > 9%
  • if patient becomes insulin therapy
  • if patient has exclusion criteria for coffee consumption
  • if patient is non-compliant with study protocol
  • if patient is pregnant
  • if patient has acute infection
  • if patient has anaemia
  • if patient has malignancies
  • if patient has autoimmune or immune compromising diseases including HIV/AIDS
  • if patient has psychiatric diseases or addiction
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01409330


Contacts
Layout table for location contacts
Contact: Lejla Zahiragic, MD 00492118104819 ext 319 lejla.zahiragic@med.uni-duesseldorf.de
Contact: Bettina Nowotny, MD, M.Sc. 00492113382575 studienzentrum@ddz.uni-duesseldorf.de

Locations
Layout table for location information
Germany
German Diabetes Center Recruiting
Duesseldorf, NRW, Germany, 40225
Contact: Lejla Zahiragic, MD    00492118104819    lejla.zahiragic@med.uni-duesseldorf.de   
Contact: Bettina Nowotny, MD    00492113382-0 ext -575    bettina.nowotny@ddz.uni-duesseldorf.de   
Sub-Investigator: Lejla Zahiragic, MD         
Sub-Investigator: Bettina Nowotny, MD, M.Sc.         
Principal Investigator: Michael Roden, Professor, MD         
Charite, Department of Internal Medicine Active, not recruiting
Berlin, Germany
University Hospital, Department of Internal Medicine III Not yet recruiting
Dresden, Germany
Contact: Ulrike Schatz, MD         
Sub-Investigator: Ulrike Schatz, MD         
Principal Investigator: Stefan Bornstein, Professor, MD         
University Hospital, Department of Internal Medicine I Recruiting
Heidelberg, Germany
Contact: Jan Groener, MD       jan.groener@med.uni-heidelberg.de   
Sub-Investigator: Jan Groener, MD         
Principal Investigator: Peter Nawroth, Professor, MD         
Klinikum der Universität München (KUM) Active, not recruiting
Munich, Germany
University Hospital, Department of Internal Medicine IV Active, not recruiting
Tübingen, Germany
Sponsors and Collaborators
German Diabetes Center
Investigators
Layout table for investigator information
Study Director: Michael Roden, Professor, MD German Diabetes Center
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: German Diabetes Center
ClinicalTrials.gov Identifier: NCT01409330    
Other Study ID Numbers: DDIET3521
First Posted: August 4, 2011    Key Record Dates
Last Update Posted: August 22, 2012
Last Verified: August 2012
Keywords provided by German Diabetes Center:
insulin sensitivity
type 2 diabetes
diet intervention
Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases